Fair 37°
Tag:

Johnson & Johnson

News
NJ COVID Cases Surge To Highest 7-Day Average Since April NJ COVID Cases Surge To Highest 7-Day Average Since April
NJ COVID Cases Surge To Highest 7-Day Average Since April COVID-19 cases continue to climb in New Jersey, the 7-day average surging higher than it's been since April, the state's Coronavirus dashboard shows. New Jersey reported another 2,471 cases and 20 confirmed deaths following Thanksgiving weekend. The uptick in cases come as we enter the busy holiday travel season and as the new Omicron variant has now been detected in the U.S.  Officials say the number of people hospitalized due to COVID-19 has also increased, with 1,052 patients confirmed or suspected of having the coronavirus across 70 of New Jersey’s 71 hospitals as of las…

SHARE

by Joe Gomez
News
Chris Rock Says He's Got COVID-19: 'Trust Me You Don't Want This' Chris Rock Says He's Got COVID-19: 'Trust Me You Don't Want This'
Chris Rock Says He's Got Covid-19: 'Trust Me You Don't Want This' Chris Rock became the latest celebrity to announce that he has the coronavirus -- and after being vaccinated. “Hey guys I just found out I have COVID," Rock tweeted Sunday. "[T]rust me you don’t want this," he added. "Get vaccinated.” Rock, 56, who has a home in Alpine, joked with Jimmy Fallon on "The Tonight Show" in May that he'd skipped the line to get the COVID-19 vaccine. “I didn’t care. I used my celebrity, Jimmy," he said. "I didn’t care. I was like, ‘Hey, step aside, Betty White. Step aside, old people. Judge Judy, kiss my ass.' I was like Billy Zane on the Titanic.” Rock's infec…

SHARE

by Jerry DeMarco
News
COVID-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says COVID-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says
Covid-19: Unvaccinated Are More Than Twice As Likely To Get Virus A Second Time, CDC Says A new study by the US Centers for Disease Control and Prevention (CDC) found that COVID-19 vaccines offer better and more protection against reinfection of the virus than just natural immunity among those who already have been infected. On Friday, Aug. 6, the CDC released the findings of a new study of nearly 1,000 Americans who previously tested positive for COVID-19 but remained unvaccinated. According to the study, those who were unvaccinated proved to be more than twice as likely to become infected for a second time than those who were fully vaccinated against the virus. Researchers …

SHARE

by Zak Failla
Business
Johnson & Johnson Recalls 5 Neutrogena, Aveeno Sunscreens Due To Carcinogen Traces Johnson & Johnson Recalls 5 Neutrogena, Aveeno Sunscreens Due To Carcinogen Traces
Johnson & Johnson Recalls 5 Neutrogena, Aveeno Sunscreens Due To Carcinogen Traces Johnson & Johnson is recalling five of its aerosol sunscreens after testing found low levels of a carcinogen in the products. On Wednesday, July 14, the company reported that low levels of benzene were found in the following products: NEUTROGENA® Beach Defense® aerosol sunscreen, NEUTROGENA® Cool Dry Sport aerosol sunscreen, NEUTROGENA® Invisible Daily™ defense aerosol sunscreen, NEUTROGENA® Ultra Sheer® aerosol sunscreen, and AVEENO® Protect + Refresh aerosol sunscreen J&J said benzene isn't an ingredient in any of the products, and it is investigating the cause.  Anyone usi…

SHARE

by Nicole Valinote
News
'Shots At The Shore': COVID Vaccines Offered At These Three NJ Beaches This Weekend 'Shots At The Shore': COVID Vaccines Offered At These Three NJ Beaches This Weekend
'Shots At The Shore': COVID Vaccines Offered At These Three NJ Beaches This Weekend Get ready for a different type of shots Down the Shore this weekend: COVID-19 shots. New Jersey Gov. Phil Murphy announced "Shots at the Shore" -- a new vaccine initiative -- in Asbury Park Friday alongside several local and county officials. Stations will be set up at the following locations from 9 a.m. to 3 p.m. Grande Arcade on the boardwalk, Asbury Park Gateway National Recreational Area, in Sandy Hook The gazebo at Pier Village, Long Branch Patients can take their picks from Moderna, Pfizer or Johnson & Johnson, and follow up for the second shot at any Walgreens pharmacy, fr…

SHARE

by Cecilia Levine
News
COVID-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC COVID-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC
Covid-19: Brand-New Data On Number Of Breakthrough Cases Among Fully Vaccinated Released By CDC The Centers for Disease Control and Prevention (CDC) has released brand-new data on the percentage of people who have become infected with COVID-19 despite being fully vaccinated. The latest info shows that the number remains extremely low. In those totals, released on Friday, April 30, more than 95 million Americans were fully vaccinated as of Monday, April 26.  To be fully vaccinated, two weeks or more must have passed since they received the second dose of the Pfizer or Moderna vaccine or the single-dose Johnson & Johnson vaccine. Of those nearly 100 million fully vaccina…

SHARE

by Joe Lombardi
News
COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women
Covid-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women Results of the largest study conducted by the Centers for Disease Control and Prevention (CDC) on the use of two-dose COVID-19 vaccines by pregnant women have been released. The new study, published this week in the New England Journal of Medicine, found that out of more than 35,000 people who were pregnant or soon to become pregnant, there is no evidence to suggest that the Pfizer or Moderna COVID vaccines pose risk during pregnancy. Little data has been released on the Johnson & Johnson one-dose vaccine, which had run into production issues before distribution was paused following rep…

SHARE

by Zak Failla
News
COVID-19: Moderna Seeks Full FDA Vaccine Approval COVID-19: Moderna Seeks Full FDA Vaccine Approval
Covid-19: Moderna Seeks Full FDA Vaccine Approval With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…

SHARE

by Zak Failla
News
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…

SHARE

by Zak Failla
News
PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot
PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot One of the six women who developed clots as a result of the Johnson & Johnson COVID-19 vaccine is a Pennsylvania woman. The vaccine's use was temporarily halted nationwide after six women between the ages of 18 and 48 experienced blood clots. The New Jersey Health Department confirms that the woman they treated for the rare vaccine side effect is a resident of Pennsylvania who was hospitalized in New Jersey. The woman’s name will not be made public, but details about her have, she is 26, from an area bordering New Jersey and is gym instructor, according to a statement from the pharmac…

SHARE

by Jillian Pikora
News
PA Hospital Chief, Senate Candidate Dr. Kevin Baumlin Pushes To Restart J&J Vaccine For Some PA Hospital Chief, Senate Candidate Dr. Kevin Baumlin Pushes To Restart J&J Vaccine For Some
PA Hospital Chief, Senate Candidate Dr. Kevin Baumlin Pushes To Restart J&J Vaccine For Some A Pennsylvania hospital official and 2022 US Senate candidate is pushing for the continuation of the Johnson & Johnson COVID-19 vaccine that was recently halted.  Dr. Kevin Baumlin -- Chief of Emergency and Urgent Services -- suggests men and older adults should be allowed to continue receiving the one-shot vaccine, which he administered 52 doses of last weekend in Philadelphia. "I did that to help save lives," the physician said. The Johnson & Johnson vaccine’s use was halted in the US, including Pennsylvania, after six women under 35 experienced blood clo…

SHARE

by Jillian Pikora
News
CDC, FDA Call For Pause On Johnson & Johnson Vaccine CDC, FDA Call For Pause On Johnson & Johnson Vaccine
CDC, FDA Call For Pause On Johnson & Johnson Vaccine The US Centers for Disease Control and Prevention and the US Food and Drug Administration are calling for a pause on the use of Johnson & Johnson's COVID-19 vaccine due to six cases of "rare and severe" blood clot cases reported. All six cases occurred among women between 18 and 48, and symptoms occurred 6 to 13 days after vaccination, FDA officials said in a joint statement. More than 6.8 million doses of the one-dose vaccine had been administered in the U.S. All Pennsylvania teachers and administrators were given the J&J vaccine. Out of the 200,000 offered the vaccine a…

SHARE

by Cecilia Levine
News
New Jersey Man Hospitalized With COVID 5 Weeks After J&J Vaccine New Jersey Man Hospitalized With COVID 5 Weeks After J&J Vaccine
New Jersey Man Hospitalized With COVID 5 Weeks After J&J Vaccine A 52-year-old New Jersey man was in the hospital with COVID-10 just five weeks after being vaccinated, the New York Post reports. Francisco Cosme of Edison received the single-dose Johnson & Johnson vaccine at the Javits Center on March 6. On April 1, he came down with a fever, chills and a cough, his daughter Michelle Torres told the NY Post. Cosme isolated himself for 10 days at a physician's instruction but was rushed to the hospital when he began having trouble breathing, the report says. He remained hospitalized April 11, with pneumonia. Meanwhile, Torres' family also teste…

SHARE

by Cecilia Levine
News
COVID-19: Millions Of J&J Doses Tossed After Factory Mixup COVID-19: Millions Of J&J Doses Tossed After Factory Mixup
Covid-19: Millions Of J&J Doses Tossed After Factory Mixup Millions of doses of the Johnson & Johnson COVID-19 vaccine were destroyed following a dosage mix-up at a production lab, prompting a delay in shipments to states. According to reports, employees at Emergent BioSolutions, a production facility in Baltimore that produces the vaccine, mixed up two ingredients, ruining approximately 15 million doses of the vaccine. Johnson & Johnson said in a statement that one batch of the drug substance at Emergent BioSolutions “did not meet quality standards” and was “never advanced to the filling and finishing stages of our manufacturing process.” …

SHARE

by Zak Failla
News
COVID-19: Rutgers Students Required To Get Vaccine By Fall, Nation's 1st University Mandate COVID-19: Rutgers Students Required To Get Vaccine By Fall, Nation's 1st University Mandate
Covid-19: Rutgers Students Required To Get Vaccine By Fall, Nation's 1st University Mandate Rutgers University will require the COVID-19 vaccine for all students who are enrolled for the 2021 fall semester, officials announced Thursday. The New Jersey college is believed to be the first in the nation to require a coronavirus shot for its more than 71,000 students before they can return to in-person classes on campus.  “We are committed to health and safety for all members of our community, and adding COVID-19 vaccination to our student immunization requirements will help provide a safer and more robust college experience for our students,” said Rutgers President Jonathan Holl…

SHARE

by Jon Craig
News
COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective
Covid-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective More reliable than the flu shot? Pfizer on Monday trumpeted a COVID-19 vaccine candidate as more than 90% effective – nearly three times better than the effectiveness of last season’s influenza vaccine. Pfizer said it hopes to have 50 million doses of the free vaccine ready by the end of this year and as many as 1.3 billion doses available next year to fight the deadly global pandemic. Two doses per person of BNT162b2 would be necessary, said the Manhattan-based drug maker, which teamed up with BioNTech of Germany to develop the booster. Pfizer plans to ask the federal Food and Drug Admini…

SHARE

by Jerry DeMarco
News
J&J: Mystery Illness Pauses Largest COVID Vaccine Trial J&J: Mystery Illness Pauses Largest COVID Vaccine Trial
J&J: Mystery Illness Pauses Largest COVID Vaccine Trial A mystery illness suffered by a participant has put the largest COVID-19 vaccine trial on hold, drug maker Johnson & Johnson announced. The New Jersey-based company – which sought 60,000 volunteers mostly over 60 – didn’t describe the illness or identify the patient in any way. “We must respect this participant's privacy,” J&J said in a statement. “We're also learning more about this participant's illness, and it's important to have all the facts before we share additional information.” J&J said it would provide transparent updates throughout the development of the randomized, …

SHARE

by Jerry DeMarco
News
NJ-Based Johnson & Johnson Pauses COVID-19 Vaccine Trial Due To Unexplained Participant Illness NJ-Based Johnson & Johnson Pauses COVID-19 Vaccine Trial Due To Unexplained Participant Illness
Nj-based Johnson & Johnson Pauses Covid-19 Vaccine Trial Due To Unexplained Participant Illness New Jersey-based Johnson & Johnson has paused its COVID-19 vaccine study because of an unexplained illness among a participant. Researchers running the 60,000 patient trial received a notice saying the "pausing rule has been met," Stat News reports. The online patient-enrolling system was subsequently closed and a meeting for the patient safety monitoring board comprised of independent committee met Monday evening, the report says. J&J -- based in New Brunswick -- declined to tell Stat News anything more than a study participant suffered an unexplained illness. The company began e…

SHARE

by Cecilia Levine